1. American College of Chest Physicians, American Thoracic Society, Asia Pacific Society of Respirology, Canadian Thoracic Society, European Respiratory Society, International Union Against Tuberculosis and Lung Disease. Smoking and health: A physician responsibility. A statement of the joint committee on smoking and health. Eur Respir J 1995; 8:1808.

2. Anthonisen, NR, Connett, JE, Kiley, JP, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. JAMA 1994; 272:1497.

3. Benowitz, NL. Pharmacologic aspects of cigarette smoking and nicotine addiction. N Engl J Med 1988; 319:1318.

4. Benowitz, NL. Pharmacokinetic considerations in understanding nicotine dependence. Ciba Found Symp 1990; 152:186.

5. Bergen, AW, Caporaso, N. Cigarette smoking. J Natl Cancer Inst 1999; 91:1365.

6. Blondal, T. Contolled trial of nicotine polacrilex gum with supportive measures. Arch Intern Med 1989; 149:1818.

7. Blondal, T, Gudmundsson, LJ, Olafsdottir, I, et al. Nicotine nasal spray with nicotine patch for smoking cessation: Randomised trial with six year follow up. BMJ 1999; 318:285.

8. Buist, AS, Sexton, GJ, Nagy, JM, et al. The effect of smoking cessation and modification on lung function. Am Rev Respir Dis 1976; 114:115.

9. Center for Disease Control. The Health Consequences of Smoking, Nicotine Addiction. A Report of the Surgeon General. U.S. Department of Health and Human Services. Public Health Service, Center for Health Promotion and Education, Office on Smoking and Health. Rockville, Maryland: U.S. Government Printing Office. NIH publication 88-8406, 1988.

10. Cornuz, J, Feskanich, D, Willett, WC, Colditz, GA. Smoking, smoking cessation, and risk of hip fracture in women. Am J Med 1999; 106:311.

11. Croghan, IT, Offord, KP, Evans, RW, et al. Cost-effectiveness of treating nicotine dependence: The Mayo Clinic experience. Mayo Clin Proc 1997; 72:917.

12. Cromwell, J, Bartosch, WJ, Fiore, MC, et al. Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. JAMA 1997; 278:1759.

13. Danielsson, T, Rossner, S, Westin, A. Open randomised trial of intermittent very low energy diet together with nicotine gum for stopping smoking in women who gained weight in previous attempts to quit. BMJ 1999; 319:490.

14. Daughton, DM, Fortmann, SP, Glover, ED. The smoking cessation efficiency of varying doses of nicotine patch delivery systems 4 to 5 years post quit day. Prevent Med 1999; 28:113.

15. Department of Health and Human Services. Health benefits of smoking cessation. A report of the Surgeon General, Washington, DC. DHHS Publication No. (CDC) 90-8416 1990.

16. Evans, N, Farkas, A, Gilpin, E, et al. Influence of tobacco marketing and exposure to smokers on adolescent susceptibility to smoking. J Natl Cancer Inst 1995; 87:1538.

17. Fageström, KO: Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict Behav 1978; 3:235.

18. Fiore, MC, Jorenby, DE, Baker, TB. Tobacco dependence and the nicotine patch. Clinical guidelines for effective use. JAMA 1992; 268:2687.

19. Flegal, KM, Troiano, RP, Pamuk, ER, et al. The influence of smoking cessation on the prevalence of overweight in the United States. N Engl J Med 1995; 333:1165.

20. Froom, P, Kristal-Boneh, E, Melamed, S, et al. Smoking cessation and body mass index of occupationally active men: The Israeli CORDIS study. Am J Public Health 1999; 89:718.

21. Glassman, AH, Jackson, WK, Walsh, BT, et al. Cigarette craving, smoking withdrawal and clonidine. Science 1984; 226:864.

22. Glover, ED, Sachs, DPL, Stitzer, ML, et al. Smoking cessation in highly dependent smokers with 4 mg nicotine polacrilex. Am J Health Behavior 1996; 20:319.

23. Goldstein, MG, Niaura, R, Willey-Lessne, C, et al. Physicians counseling smokers. A population-based survey of patients' perceptions of health care provider-delivered smoking cessation interventions. Arch Intern Med 1997; 157:1313.

24. Hajek, P, Jackson,P, Belcher, M. Long-term use of of nicotine chewing gum. JAMA, 1988; 260:1593

25. Hajek, P, West, R, Foulds, J, et al. Randomized comparative trial of nicotine polacrilex, a transdermal patch, nasal spray, and an inhaler. Arch Intern Med 1999; 159:2033

26. Hall, SM, Tunstall, CD, Grinsberg, D, et. Al. Nicotine gum and behavioral treatment: A placebo control trial. J Consult Clin Psychology, 1987; 55:603.

27. Hanrahan JP, Sherman, CB, Bresnitz, EA, et al. Cigarette smoking and health. Am J Respir Crit Care Med 1996; 153:861.

28. Henningfield, JE, Miyasato, K, Jasinski, DR. Abuse liability and pharmacodynamic characteristics of intravenous and inhaled nicotine. J Pharmacol Exp Ther 1985; 234:1.

29. Hughes, JR, Goldstein, MG, Hurt, RD, Shiffman, S. Recent advances in the pharmacotherapy of smoking. JAMA 1999; 281:72.

30. Humerfelt, S, Eide, GE, Kvale, G, et al. Effectiveness of postal smoking cessation advice: A randomized controlled trial in young men with reduced FEV1 and asbestos exposure. Eur Respir J 1998; 11:284.

31. Hurt, RD, Sachs, DPL, Glover, ED, et al. A Comparison of sustained-release buproprion and placebo for smoking cessation. N Engl J Med 1997; 337:1195.

32. Jorenby, DE, Leischow, SJ, Nides, MA, et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 1999; 340:685.

33. Joseph, AM, Norman, SM, Ferry, LH, et al. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med 1996; 335:1792.

34. Kaner, RE, Connett, JE, Williams, DE, et al. Effects of randomized assignment to a smoking cessation intervention and changes in smoking habits on respiratory symptoms in smokers with early chronic obstructive pulmonary disease: The lung health study. Am J Med 1999; 106:410.

35. Killen, J, Fortmann, SP, Telch, MJ, et al . Are heavy smokers different than Ligth smokers? JAMA, 1988; 260:1581.

36. King, TE. Bronchiolitis. In: Schwarz, MI, King, TE, (Eds), Interstitial Lung Disease, 2nd ed, Mosby Year Book, St. Louis, Missouri, 1993, pp. 463-495.

37. Krall, EA, Dawson-Hughes, B. Smoking increases bone loss and decreases intestinal calcium absorption. J Bone Miner Res 1999; 14:215.

38. Kurata, JH, Nogawa, AN. Meta-analysis of risk factors for peptic ulcer. Nonsteroidal antiinflammatory drugs, Helicobacter pylori, and smoking. J Clin Gastroenterol 1997; 24:2.

39. Mahmarian, JJ, Moye, LA, Nasser, GA, et al. Nicotine patch therapy in smoking cessation reduces the extent of exercise-induced myocardial ischemia. J Am Coll Cardiol 1997; 30:125.

40. Manley, M, Epps, RP, Husten, C, et al. Clinical interventions in tobacco control. JAMA 1991; 266:3172.

41. Mikkelsen, KL, Tonnesen, P, Norregaard, J. Three-year outcome of two- and three-year sustained abstainers from a smoking cessation study with nicotine patches. J Smok Rel Dis 1994; 5:95.

42. Motley, RJ, Rhodes, J, Ford, GA, et al. Time relationships between cessation of smoking and onset of ulcerative colitis. Digestion 1987; 37:125.

43. Murray, RP, Bailey, WC, Daniels, K, et al. Safety of nicotine polacrilex gum used by 3,094 participants in the Lung Health Study. Lung Health Study Research Group. Chest 1996; 109:438.

44. Nuorti, JP, Butler, JC, Farley, MM, et al. Cigarette smoking and invasive pneumococcal disease. N Engl J Med 2000; 342:681.

45. O'Hara, P, Connett, JE, Lee, WW, et al. Early and late weight gain following smoking cessation in the lung health study. Am J Epidemiol 1998; 148:821.

46.Prochaska, JO, DiClemente, CC, Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psycology 1983; 51:390.

47. Prochazka, AV, Petty, TL, Nett, L, et al. Transdermal clonidine reduced smoke withdrawal symptoms but did not increase smoking cessation. Arch Intern Med 1992; 152:2065.

48. Raw, M, McNeill, A, West, R. Smoking cessation guidelines for health professionals. A guide to effective smoking cessation interventions for the health care system. Thorax 1998; 53(suppl 5):S1.

49. Reid, RD, Pipe, A, Dafoe, WA. Is telephone counseling a useful addition to physician advice and nicotine replacement therapy in helping patients to stop smoking? A randomized controlled trial. CMAJ 1999; 160:1577.

50. Richmond, RL, Kehow, L, de Almeida Neto, AC. Three year continuous abstinence in a smoking cessation study using the nicotine transdermal patch. Heart 1997; 78:617.

51. Schwartz, JL. Review and evaluation of smoking cessation methods: The United States and Canada, 1978-1985. NIH publication No 87-2940 1987; 1125-156.

52. Segal, DS, Kuczenski, R. Behavioral pharmacology of amphetamine. In: Cho, AK, Segal, DS, (Eds), Amphetamine and Its Analogs, Academic Press Inc, San Diego, 1994, pp. 115-150.

53. Snider, G. Emphysema: The first two centuries--and beyond. Am Rev Respir Dis 1992; 146:1615.

54. Stapleton, JA, Sutherland, G, Russell, MA. How much does relapse after one year erode effectiveness of smoking cessation treatments? Long term follow up of randomised trial of nicotine nasal spray. BMJ 1998; 316:830.

55. The Transdermal Nicotine Study Group. Transdermal nicotine for smoking cessation. Six-month results from two multicenter controlled clinical trials. JAMA 1991; 266:3133.

56. Tønnesen, P, Fryd, V, Hansen M, et. al. Effect of nicotine chewing gum in combination with group counseling on the cessation of smoking. N Engl J Med, 1988; 318:15.

57. Tønnesen, P, Paoletti, P, Gustavsson, G, et al. Higher dosage nicotine patches increase one-year smoking cessation rates: Results from the European CEASE trial. Collaborative European Anti-Smoking Evaluation. European Respiratory Society. Eur Respir J 1999; 13:238.

58. U.S. Department of Health and Human Services. The health consequences of smoking. A report of the Surgeon General. No. 84-50205, 1984.

59. U.S. Department of Health and Human Services. Smoking Cessation: Information for Specialists. Agency for Health Care Policy and Research, Rockville, Maryland, Publication No. 96-0694, 1996.

60. Von Essen, S, West, W, Sitorius, M, Rennard, SI. Complete resolution of radiographic changes of histiocytosis X after smoking cessation. Chest 1990; 98:765.

61. Wise, RA, Enright, PL, Connett, JE, et al. Effect of weight gain on pulmonary function after smoking cessation in the Lung Health Study. Am J Respir Crit Care Med 1998; 157:866.

62. Working Group for the Study of Transdermal Nicotine in Patients with Coronary Artery Disease. Nicotine replacement therapy for patients with coronary artery disease. Arch Intern Med 1994; 154:989.